Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022

19 Aug 2022 - Baar, 19 August 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligo-nucleotide-based active pharmaceutical ingredients, today announced its detailed results […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide provides market update

12 Jul 2022 - Media Release – ad hoc announcement pursuant to Art. 53 LR Baar, 12 July 2022 – PolyPeptide Group AG (PolyPeptide), a global leader in peptide and […]

Read more
Business news

PolyPeptide wins Malmö Life Science Business Award

28 Jun 2022 - Malmö, 21 June 2022 We are proud of our site in Malmö, Sweden, for winning the Life Science Business Award of the city (Malmö Näringslivspris Life […]

Read more
Media releases

Monika Casanova joining PolyPeptide as CHRO and member of the PMC

9 May 2022 - Baar, 9 May 2022 – PolyPeptide Group AG (PolyPeptide), a global leader in peptide development and manufacturing, today announced that Monika Casanova has joined the Group […]

Read more
Media releases

PolyPeptide announces results of the annual General Meeting 2022

26 Apr 2022 - Zug, 26 April 2022 – PolyPeptide Group AG (PolyPeptide), a global leader in peptide development and manufacturing, today announced that the shareholders approved all proposals put […]

Read more
Media releases

PolyPeptide publishes invitation to the annual General Meeting 2022

1 Apr 2022 - Zug, 1 April 2022 – PolyPeptide Group AG (PolyPeptide), a global leader in peptide custom development and manufacturing, published today the invitation to its first annual […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide achieves strong profitable growth in 2021

15 Mar 2022 - Media Release – ad hoc announcement pursuant to Art. 53 LR   PolyPeptide achieves strong profitable growth in 2021 Zug, 15 March 2022 – PolyPeptide Group […]

Read more
Business news

Efficient and sustainable solutions for large scale peptide manufacturing

22 Dec 2021 - We are happy to share the latest scientific publication from the PolyPeptide Innovation Team, Dr. Renan Revetti Duran, Innovation Scientist and Dr. Olivier Ludemann-Hombourger, Global Director, […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide Group appoints Neil Thompson as Director Global Sales and Marketing and member of the Executive Committee, succeeding Jan Christensen

1 Dec 2021 - PolyPeptide Group / Key word(s): Personnel PolyPeptide Group appoints Neil Thompson as Director Global Sales and Marketing and member of the Executive Committee, succeeding Jan Christensen […]

Read more